DE3786806D1 - Reinigung von keuchhustenantigenen. - Google Patents

Reinigung von keuchhustenantigenen.

Info

Publication number
DE3786806D1
DE3786806D1 DE8787300387T DE3786806T DE3786806D1 DE 3786806 D1 DE3786806 D1 DE 3786806D1 DE 8787300387 T DE8787300387 T DE 8787300387T DE 3786806 T DE3786806 T DE 3786806T DE 3786806 D1 DE3786806 D1 DE 3786806D1
Authority
DE
Germany
Prior art keywords
lpf
produced
fha
fimbrial
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787300387T
Other languages
English (en)
Other versions
DE3786806T2 (de
Inventor
Andrew Robinson
Lawrence Ian Irons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Protection Agency
Original Assignee
HEALTH LAB SERVICE BOARD
Public Health Laboratory Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEALTH LAB SERVICE BOARD, Public Health Laboratory Service Board filed Critical HEALTH LAB SERVICE BOARD
Publication of DE3786806D1 publication Critical patent/DE3786806D1/de
Application granted granted Critical
Publication of DE3786806T2 publication Critical patent/DE3786806T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE87300387T 1986-01-20 1987-01-16 Reinigung von Keuchhustenantigenen. Expired - Lifetime DE3786806T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868601279A GB8601279D0 (en) 1986-01-20 1986-01-20 Purification of pertussis antigens

Publications (2)

Publication Number Publication Date
DE3786806D1 true DE3786806D1 (de) 1993-09-09
DE3786806T2 DE3786806T2 (de) 1993-12-09

Family

ID=10591636

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87300387T Expired - Lifetime DE3786806T2 (de) 1986-01-20 1987-01-16 Reinigung von Keuchhustenantigenen.

Country Status (11)

Country Link
US (1) US4784589A (de)
EP (1) EP0231083B1 (de)
JP (1) JP2538224B2 (de)
KR (1) KR950010323B1 (de)
CN (1) CN1028206C (de)
AT (1) ATE92335T1 (de)
AU (1) AU592727B2 (de)
CA (1) CA1280693C (de)
DE (1) DE3786806T2 (de)
DK (1) DK172936B1 (de)
GB (1) GB8601279D0 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
CA1341123C (en) * 1988-10-27 2000-10-17 David A. Relman Filamentous hemagglutinin of b. pertussis
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5391715A (en) * 1989-11-06 1995-02-21 Smithkline Beecham Biologicals Method for isolating and purifying bordetella pertussis antigenic factors
DE69025375T2 (de) 1989-11-06 1996-08-01 Smithkline Beecham Biolog Verfahren
JP3035712B2 (ja) * 1990-02-12 2000-04-24 スミスクライン ビーチャム バイオロジカルズ(エス ア) 新規なワクチンおよびそのための方法
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
WO1995029934A1 (en) * 1994-04-28 1995-11-09 Takeda Chemical Industries, Ltd. Method of separating protective components of bordetella pertussis
EP1234579A1 (de) * 1995-05-04 2002-08-28 Aventis Pasteur Limited Azelluläre Pertussis-Impfstoffe und Verfahren zu deren Herstellung
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
MY172181A (en) 2013-03-08 2019-11-15 Janssen Vaccines & Prevention Bv Acellular pertussis vaccine
CN110358802B (zh) * 2019-08-16 2021-06-18 长春百克生物科技股份公司 一种去除百日咳组分菌毛蛋白2/3内毒素的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Lpf−haの精製法
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin

Also Published As

Publication number Publication date
DK27287D0 (da) 1987-01-19
DK27287A (da) 1987-07-21
ATE92335T1 (de) 1993-08-15
US4784589A (en) 1988-11-15
DK172936B1 (da) 1999-10-11
EP0231083A3 (en) 1988-06-08
EP0231083A2 (de) 1987-08-05
JPS62234031A (ja) 1987-10-14
CN1028206C (zh) 1995-04-19
AU6766487A (en) 1987-07-23
CA1280693C (en) 1991-02-26
GB8601279D0 (en) 1986-02-26
DE3786806T2 (de) 1993-12-09
AU592727B2 (en) 1990-01-18
CN87100399A (zh) 1987-09-09
KR870006902A (ko) 1987-08-13
JP2538224B2 (ja) 1996-09-25
EP0231083B1 (de) 1993-08-04
KR950010323B1 (ko) 1995-09-14

Similar Documents

Publication Publication Date Title
DE3786806D1 (de) Reinigung von keuchhustenantigenen.
DK496485D0 (da) Transformation af gaer-stammer af slaegten pichia
MX9708481A (es) Vacunas acelulares de pertussis y metodos de preparacion de las mismas.
ATE107535T1 (de) Gaschromatographische methode zur trennung von wasserstoffisotopen.
DK0522291T3 (da) Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette
ATE97448T1 (de) Verfahren zur isolierung von ca 125-antigen.
ATE47820T1 (de) Verfahren zur reinigung von abwasser.
ATE74007T1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
EP0158317A3 (en) Biologic and method of preparing same
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
JPS5464683A (en) Preparation of unicellular protein
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
DK0408742T3 (da) Fremgangsmåde til fremstilling og rensning af hepatitis B vaccine
DK222887A (da) Fremgangsmaade til fremstilling af l-aminosyrer ved fermentering af alfa-ketocarboxylsyrer
FI881294A0 (fi) FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi
JPS5539730A (en) Preparation of ubiquinone q10
JPS5588695A (en) Removal of methylguanidine
JPS6485092A (en) Production of protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MICROBIOLOGICAL RESEARCH AUTHORITY, SALISBURY, GB

8327 Change in the person/name/address of the patent owner

Owner name: HEALTH PROTECTION AGENCY, SALISBURY, WILTSHIRE, GB